FDA WARNING_LETTER - Dr. Joel Kaplan Inc. - July 17, 2013

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Dr. Joel Kaplan Inc.

Record Details

On May 1, 2014, the FDA issued a Warning Letter to Dr. Joel Kaplan, Inc. following an inspection from June 19 to July 17, 2013. The firm, operating from a retail store and websites (www.drjoelkaplan.com, www.getbiggertoday.com), manufactures and sells the MegaVac System (an external penile rigidity device) and the Clitoris Enhancement System, along with dietary supplements.

The MegaVac System was found to be adulterated under 21 U.S.C. § 351(h) due to non-conformity with Quality System (QS) regulation (21 CFR Part 820). Specific violations included failure to maintain device history records (21 CFR 820.184) for repacked MegaVac pumps and failure to establish complaint handling procedures (21 CFR 820.198(a)).

Furthermore, the MegaVac System was deemed adulterated under 21 U.S.C. § 351(f)(1)(B) because the firm lacked an approved premarket approval (PMA) or investigational device exemption (IDE). It was also misbranded under 21 U.S.C. § 352(o) for major changes to its intended use (e.g., penis enlargement, curvature correction) without

Company: Dr. Joel Kaplan Inc.
Inspection Date: July 17, 2013
Product Type: Devices
Office: Los Angeles District Office
People: Alonza E. Cruse (Director)
Hugo Cornejo (Cofounder )

Open in Dashboard

ID · a4ff8472-309f-4017-868d-ffd3f515db4e

Violation Codes10

21 U.S.C. 321(h)21 U.S.C. 351(h)21 CFR 82021 CFR 820.18421 CFR 820.198(a)21 U.S.C. 351(f)(1)(B)21 U.S.C. 360e(a)21 U.S.C. 360j(g)21 U.S.C. 352(o)21 U.S.C. 360(k)

Full citation text and observation details available on the Dashboard.